Vimseltinib 14 mg; 20 mg; 30 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 14 mg; 20 mg; 30 mg
Reference Brands: Romvimza
Category: Oncology Cancer Care
Vimseltinib is used in adults to treat giant cell tumor of the tendon sheath (also called tenosynovial giant cell tumor) that is not likely to improve with surgery. Before taking this medicine, tell your doctor if you have or have ever had an allergy to aspirin or food dye or liver disease. Vimseltinib can harm an unborn baby if the mother or the father is using vimseltinib.
Manufacture or export Vimseltinib? List it or send an offer →
Product Description:
Vimseltinib is an oral CSF1R (colony-stimulating factor 1 receptor) inhibitor, sold as Romvimza by Deciphera Pharmaceuticals, part of the Ono Pharmaceutical group. The US FDA approved it in February 2025 for adults with symptomatic tenosynovial giant cell tumour (TGCT) where surgery would make function worse or cause severe harm.
TGCT is a rare, usually non-cancerous tumour of the joint lining and tendon sheaths, driven by too much CSF1. Blocking the CSF1 receptor reduces the cells that make up most of the tumour. Vimseltinib is taken as capsules twice a week.
Sourcing notes. Originator product, on patent, no generic. Supply is through authorised distribution, or named-patient import where it is not registered. We also handle licensing and development enquiries ahead of patent expiry.
How Vimseltinib is supplied today, and licensing ahead of patent expiry
Where vimseltinib is approved
Checked 3 Oct 2026| Market | Status | Brand · regulator · date |
|---|---|---|
| United States | Approved | Romvimza · FDA · Feb 2025 |
| European Union | Approved | Romvimza · European Commission · Sep 2025 |
| Generic / biosimilar | None | None approved as of the check date |
Not approved in your country? A hospital or doctor can often still import it for a named patient, through a special-access, import-permit or compassionate-use route. We confirm which route applies in your country and the documents needed before quoting. Ask about named-patient supply →
Frequently Asked Questions
Vimseltinib is used for the treatment of adults with symptomatic tenosynovial giant cell tumor (TGCT) when surgical removal of the tumor would cause severe complications or functional disability. It works by blocking the CSF1R receptor, which helps reduce the growth and spread of tumor cells in the affected joints or tissues.
Vimseltinib is a small-molecule compound formulated as oral capsules. It contains the active ingredient vimseltinib, a selective colony-stimulating factor 1 receptor (CSF1R) inhibitor.
The trade name of Vimseltinib is Romvimza.
Vimseltinib is developed and manufactured by Deciphera Pharmaceuticals, LLC, which is part of the Ono Pharmaceutical Group.
The generic name of the product is Vimseltinib.
The brand name of the product is Romvimza.
Romvimza is supplied by Deciphera Pharmaceuticals, part of the Ono Pharmaceutical group. The manufacturing site for each batch is shown on the pack and its certificate of analysis.
Romvimza (Vimseltinib) is developed and sold by Deciphera Pharmaceuticals (Ono Pharmaceutical). PharmaTradz handles enquiries for authorised supply of the originator product, named-patient import where it is not registered, and licensing or development work ahead of patent expiry.
Related Products
Leuprolide Acetate
Strength:
3.75 mg, 7.5 mg, 11.25 mg, 22.5 mg
Form: Injection
Reference Brands: Lupron (USA), Eligard (USA/EU)
View Details
Pembrolizumab Inj
Strength:
25 mg/mL
Form: Injection
Reference Brands: Keytruda (USA/EU)
View Details
Daratumumab
Strength:
100 mg/5 mL, 400 mg/20 mL
Form: Injection
Reference Brands: Darzalex (USA/EU)
View Details
Cabozantinib
Strength:
20 mg, 40 mg, 60 mg, 80mg, 100mg
Form: Tablets / Capsules
Reference Brands: Cometriq (USA), Cabometyx (USA/EU)
View Details
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View Details
Flutamide
Strength:
125mg, 250mg
Form: Tablets / Capsules
Reference Brands: Eulexin (USA/EU)
View Details
Decitabine
Strength:
50 mg/vial (5 mg/mL once reconstituted)
Form: Injection
Reference Brands: Dacogen (USA)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit
